Categories: The Charlton Centre

Updated COVID-19 Vaccine Information

With updated COVID-19 vaccines becoming available as booster doses to offer better protection against variants of the SARS-COV-2 virus, it is important to be aware of who is eligible to receive them.

At Charlton Health, we continue to serve immunocompromised patients who are being treated for a variety of autoimmune diseases. We recognize and acknowledge the value that these new vaccines bring to better protect our patients. Currently, in Canada, one new bivalent vaccine (manufactured by Moderna) can be given as a booster dose for individuals who have completed the primary series of COVID-19 vaccines.

As of September 12, 2022, Ontario’s Ministry of Health has recognized the following high-risk individuals to be eligible for the new COVID-19 bivalent Moderna booster vaccine dose (regardless of how many booster doses the individual had received in the past):

  1. Residents of long-term care homes, retirement homes, Elder Care Lodges and individuals living in other congregate settings that provide assisted-living and health services
  2. Individuals aged 70 years and older
  3. Individuals who are 12 years and older with moderately to severely immunocompromising conditions
    • For those between the age of 12-17 years of age with moderately to severely immunocompromising conditions, a booster dose of the bivalent Moderna COVID-19 vaccine may be offered off-label based on clinical discretion
  4. Individuals that are 18 years and older who identify as First Nations, Inuit, or Metis and their non-Indigenous household members aged 18 years and older
  5. Pregnant individuals that are 18 years and older
  6. Healthcare workers that are 18 years and older

As of September 26, 2022, all individuals 18 years and older will be eligible to receive a fall COVID-19 bivalent (Moderna) booster dose (regardless of how many booster doses the individual had received in the past).

Table 2 from the COVID-19 Vaccine Guidance published by Ontario’s Ministry of Health provides the recommended timing interval between the primary series and booster doses of COVID-19 vaccines. It is important to highlight that for those individuals who are moderately and severely immunocompromised individuals, a primary series consists of 3 vaccine doses. The guidance also highlights the timing of the vaccine doses relative to previous infections, which would be important information for individuals who may have recently contracted COVID-19 and want added protection from the booster doses.

For more information on these updates, you can review the guidance here.

**Please note that this is only the latest information as of September 9, 2022. As more information on the growing topic becomes available, the guidance will likely also be updated.

Kunal Bhatt, RPh, PharmD, HBSc is a staff pharmacist for Charlton Health. As a 2020 PharmD graduate from the University of Toronto, Kunal possesses a diverse range of experiences from working in hospital and community pharmacy settings. Since January 2021, Kunal was heavily invested in contributing to the efforts against COVID-19 by administering upwards of 5000 COVID-19 vaccines at William Osler Health System’s vaccination clinics.

admin

Share
Published by
admin

Recent Posts

Happy Back-to-School!

This week, many will return to school, and it's no secret that the back-to-school season…

1 week ago

Staying Hydrated in the Summer

Staying well hydrated is important in every season, but it becomes especially crucial during thesummer.…

3 weeks ago

World Hepatitis Day

Last week, on July 28th, we observed World Hepatitis Day, a day dedicated to raising…

1 month ago

Traveling This Summer with Biologics? Here’s What You Need to Know

Summer is a great time to get out and see new sights. Whether you're planning…

2 months ago

Summer Sun Safety

Now that the warmer weather is here, many of us are spending more time enjoying…

2 months ago

New Biosimilars of Xolair and Actemra Now Available: Omlyclo and Tyenne

Biosimilars are becoming more common in Canada, offering patients trusted alternatives to the originator biologic medication. Biosimilars…

3 months ago